Mirova US LLC Purchases 2,769 Shares of Colgate-Palmolive Company $CL

Mirova US LLC raised its position in Colgate-Palmolive Company (NYSE:CL) by 17.2% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 18,880 shares of the company’s stock after acquiring an additional 2,769 shares during the period. Mirova US LLC’s holdings in Colgate-Palmolive were worth $1,716,000 as of its most recent filing with the SEC.

Other institutional investors have also recently bought and sold shares of the company. Cornerstone Wealth Management LLC raised its stake in shares of Colgate-Palmolive by 1.2% during the 1st quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company’s stock worth $847,000 after purchasing an additional 110 shares in the last quarter. Grimes & Company Inc. raised its stake in shares of Colgate-Palmolive by 1.0% during the 2nd quarter. Grimes & Company Inc. now owns 12,495 shares of the company’s stock worth $1,136,000 after purchasing an additional 118 shares in the last quarter. Redhawk Wealth Advisors Inc. raised its stake in shares of Colgate-Palmolive by 2.4% during the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company’s stock worth $497,000 after purchasing an additional 129 shares in the last quarter. MONECO Advisors LLC raised its stake in shares of Colgate-Palmolive by 2.2% during the 1st quarter. MONECO Advisors LLC now owns 6,051 shares of the company’s stock worth $567,000 after purchasing an additional 133 shares in the last quarter. Finally, Ledyard National Bank raised its stake in shares of Colgate-Palmolive by 4.5% during the 1st quarter. Ledyard National Bank now owns 3,094 shares of the company’s stock worth $290,000 after purchasing an additional 134 shares in the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Up 2.0%

CL opened at $78.99 on Wednesday. Colgate-Palmolive Company has a 1-year low of $77.09 and a 1-year high of $102.61. The stock’s fifty day simple moving average is $82.95 and its 200 day simple moving average is $88.15. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79. The stock has a market cap of $63.84 billion, a PE ratio of 22.19, a price-to-earnings-growth ratio of 4.03 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share for the quarter, topping the consensus estimate of $0.89 by $0.03. The firm had revenue of $5.11 billion for the quarter, compared to analysts’ expectations of $5.03 billion. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The company’s quarterly revenue was up 1.0% compared to the same quarter last year. During the same quarter last year, the business earned $0.91 EPS. As a group, research analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be given a dividend of $0.52 per share. The ex-dividend date is Friday, October 17th. This represents a $2.08 annualized dividend and a yield of 2.6%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.43%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the company. Morgan Stanley dropped their price objective on Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a research note on Monday, August 4th. Piper Sandler assumed coverage on Colgate-Palmolive in a research note on Friday. They set a “neutral” rating and a $84.00 price objective on the stock. Barclays dropped their price objective on Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 1st. Citigroup dropped their price target on Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a research note on Monday, August 4th. Finally, The Goldman Sachs Group dropped their price target on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating on the stock in a research note on Thursday, October 2nd. Seven investment analysts have rated the stock with a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $94.83.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.